AEG-1 knockdown markedly augmented the anti-HCC activity of Dox and 5-FU, indicating that PAMAM-AEG-1si can be combined with standard chemotherapy or TKIs [183,212]. This evidence concerns the gene MTDH and hepatocellular carcinoma.